This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinyamu, H. K.
Right arrow Articles by Archer, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinyamu, H. K.
Right arrow Articles by Archer, T. K.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2003, p. 5867-5881, Vol. 23, No. 16
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.16.5867-5881.2003

Estrogen Receptor-Dependent Proteasomal Degradation of the Glucocorticoid Receptor Is Coupled to an Increase in Mdm2 Protein Expression

H. Karimi Kinyamu and Trevor K. Archer*

Chromatin and Gene Expression Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709

Received 19 March 2003/ Accepted 27 May 2003

Glucocorticoids and estrogens regulate a number of vital physiological processes. We developed a model breast cancer cell line, MCF-7 M, to examine potential mechanisms by which the ligand-bound estrogen receptor (ER) regulates glucocorticoid receptor (GR)-mediated transcription. MCF-7 cells, which endogenously express ER{alpha}, were stably transfected with mouse mammary tumor virus promoter-luciferase (MMTV-LUC) reporter and GR expression constructs. Our results demonstrate that treatment with estrogen agonists (17ß-estradiol [E2], diethylstilbestrol, genistein), but not antagonists (tamoxifen or raloxifene), for 48 h inhibits GR-mediated MMTV-LUC transcription and chromatin remodeling. Furthermore, estrogen agonists inhibit glucocorticoid induction of p21 mRNA and protein levels, suggesting that the repressive effect applies to other GR-regulated genes and proteins in MCF-7 cells. Importantly, GR transcriptional activity is compromised because treatment with estrogen agonists down regulates GR protein levels. The protein synthesis inhibitor cycloheximide and the proteasome inhibitor MG132 block E2-mediated decrease in GR protein levels, suggesting that estrogen agonists down regulate the GR via the proteasomal degradation pathway. In support of this, we demonstrate that E2-mediated GR degradation is coupled to an increase in p53 and its key regulator protein Mdm2 (murine double minute 2), an E3 ubiquitin ligase shown to target the GR for degradation. Using the chromatin immunoprecipitation assay, we demonstrate an E2-dependent recruitment of ER{alpha} to the Mdm2 promoter, suggesting a role of ER in the regulation of Mdm2 protein expression and hence the enhanced GR degradation in the presence of estrogen agonists. Our study shows that cross talk between the GR and ER involves multiple signaling pathways, indicative of the mechanistic diversity within steroid receptor-regulated transcription.

* Corresponding author. Mailing address: Chromatin and Gene Expression Section, Laboratory of Reproductive and Developmental Toxicology, National Institutes of Health, 111 Alexander Dr., P.O. Box 12233 (MD E4-06), Research Triangle Park, NC 27709. Phone: (919) 316-4565. Fax: (919) 316-4566. E-mail: archer1{at}niehs.nih.gov.

Molecular and Cellular Biology, August 2003, p. 5867-5881, Vol. 23, No. 16
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.16.5867-5881.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Zhang, Y., Leung, D. Y. M., Nordeen, S. K., Goleva, E. (2009). Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation. J. Biol. Chem. 284: 24542-24552 [Abstract] [Full Text]  
  • Carraro, L., Ferraresso, S., Cardazzo, B., Romualdi, C., Montesissa, C., Gottardo, F., Patarnello, T., Castagnaro, M., Bargelloni, L. (2009). Expression profiling of skeletal muscle in young bulls treated with steroidal growth promoters. Physiol. Genomics 38: 138-148 [Abstract] [Full Text]  
  • Bitto, A., Polito, F., Burnett, B., Levy, R., Di Stefano, V., Armbruster, M. A., Marini, H., Minutoli, L., Altavilla, D., Squadrito, F. (2009). Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats. J Endocrinol 201: 321-328 [Abstract] [Full Text]  
  • Gopinathan, L., Hannon, D. B., Peters, J. M., Vanden Heuvel, J. P. (2009). Regulation of Peroxisome Proliferator-Activated Receptor-{alpha} by MDM2. Toxicol Sci 108: 48-58 [Abstract] [Full Text]  
  • Morishima, Y., Wang, A. M., Yu, Z., Pratt, W. B., Osawa, Y., Lieberman, A. P. (2008). CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins. Hum Mol Genet 17: 3942-3952 [Abstract] [Full Text]  
  • Greer Card, D. A., Hebbar, P. B., Li, L., Trotter, K. W., Komatsu, Y., Mishina, Y., Archer, T. K. (2008). Oct4/Sox2-Regulated miR-302 Targets Cyclin D1 in Human Embryonic Stem Cells. Mol. Cell. Biol. 28: 6426-6438 [Abstract] [Full Text]  
  • Lum, S. S., Chua, H. W., Li, H., Li, W.-F., Rao, N., Wei, J., Shao, Z., Sabapathy, K. (2008). MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population. Carcinogenesis 29: 754-761 [Abstract] [Full Text]  
  • Conway-Campbell, B. L., McKenna, M. A., Wiles, C. C., Atkinson, H. C., de Kloet, E. R., Lightman, S. L. (2007). Proteasome-Dependent Down-Regulation of Activated Nuclear Hippocampal Glucocorticoid Receptors Determines Dynamic Responses to Corticosterone. Endocrinology 148: 5470-5477 [Abstract] [Full Text]  
  • Sayeed, A., Konduri, S. D., Liu, W., Bansal, S., Li, F., Das, G. M. (2007). Estrogen Receptor {alpha} Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis. Cancer Res. 67: 7746-7755 [Abstract] [Full Text]  
  • Kinyamu, H. K., Archer, T. K. (2007). Proteasome Activity Modulates Chromatin Modifications and RNA Polymerase II Phosphorylation To Enhance Glucocorticoid Receptor-Mediated Transcription. Mol. Cell. Biol. 27: 4891-4904 [Abstract] [Full Text]  
  • Duong, V., Boulle, N., Daujat, S., Chauvet, J., Bonnet, S., Neel, H., Cavailles, V. (2007). Differential Regulation of Estrogen Receptor {alpha} Turnover and Transactivation by Mdm2 and Stress-Inducing Agents. Cancer Res. 67: 5513-5521 [Abstract] [Full Text]  
  • Zhao, C., Matthews, J., Tujague, M., Wan, J., Strom, A., Toresson, G., Lam, E. W-F., Cheng, G., Gustafsson, J.-A., Dahlman-Wright, K. (2007). Estrogen Receptor {beta}2 Negatively Regulates the Transactivation of Estrogen Receptor {alpha} in Human Breast Cancer Cells. Cancer Res. 67: 3955-3962 [Abstract] [Full Text]  
  • Fu, D., Roufogalis, B. D. (2007). Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation. Am. J. Physiol. Cell Physiol. 292: C1543-C1552 [Abstract] [Full Text]  
  • Hebbar, P. B., Archer, T. K. (2007). Chromatin-dependent Cooperativity between Site-specific Transcription Factors in Vivo. J. Biol. Chem. 282: 8284-8291 [Abstract] [Full Text]  
  • Hu, W., Feng, Z., Ma, L., Wagner, J., Rice, J. J., Stolovitzky, G., Levine, A. J. (2007). A Single Nucleotide Polymorphism in the MDM2 Gene Disrupts the Oscillation of p53 and MDM2 Levels in Cells. Cancer Res. 67: 2757-2765 [Abstract] [Full Text]  
  • LaRusch, G. A., Jackson, M. W., Dunbar, J. D., Warren, R. S., Donner, D. B., Mayo, L. D. (2007). Nutlin3 Blocks Vascular Endothelial Growth Factor Induction by Preventing the Interaction between Hypoxia Inducible Factor 1{alpha} and Hdm2. Cancer Res. 67: 450-454 [Abstract] [Full Text]  
  • Shao, R., Egecioglu, E., Weijdegard, B., Ljungstrom, K., Ling, C., Fernandez-Rodriguez, J., Billig, H. (2006). Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors.. J Endocrinol 190: 857-870 [Abstract] [Full Text]  
  • Alarid, E. T. (2006). Lives and Times of Nuclear Receptors. Mol. Endocrinol. 20: 1972-1981 [Abstract] [Full Text]  
  • Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., Bartel, F., Taubert, H., Wuerl, P., Hait, W., Toppmeyer, D., Offit, K., Levine, A. J. (2006). MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner.. Cancer Res. 66: 5104-5110 [Abstract] [Full Text]  
  • Heitzer, M. D, DeFranco, D. B. (2006). Mechanism of Action of Hic-5/Androgen Receptor Activator 55, a LIM Domain-Containing Nuclear Receptor Coactivator. Mol. Endocrinol. 20: 56-64 [Abstract] [Full Text]  
  • Li, M., Zhang, Z., Hill, D. L., Chen, X., Wang, H., Zhang, R. (2005). Genistein, a Dietary Isoflavone, Down-Regulates the MDM2 Oncogene at Both Transcriptional and Posttranslational Levels. Cancer Res. 65: 8200-8208 [Abstract] [Full Text]  
  • Wang, X., DeFranco, D. B. (2005). Alternative Effects of the Ubiquitin-Proteasome Pathway on Glucocorticoid Receptor Down-Regulation and Transactivation Are Mediated by CHIP, an E3 Ligase. Mol. Endocrinol. 19: 1474-1482 [Abstract] [Full Text]  
  • Kinyamu, H K, Chen, J, Archer, T K (2005). Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 34: 281-297 [Abstract] [Full Text]  
  • Brady, M., Vlatkovic, N., Boyd, M. T. (2005). Regulation of p53 and MDM2 Activity by MTBP. Mol. Cell. Biol. 25: 545-553 [Abstract] [Full Text]  
  • Gaughan, L., Logan, I. R., Neal, D. E., Robson, C. N. (2005). Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res 33: 13-26 [Abstract] [Full Text]  
  • Paajarvi, G., Viluksela, M., Pohjanvirta, R., Stenius, U., Hogberg, J. (2005). TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 26: 201-208 [Abstract] [Full Text]  
  • Hoang, T., Fenne, I. S., Cook, C., Borud, B., Bakke, M., Lien, E. A., Mellgren, G. (2004). cAMP-dependent Protein Kinase Regulates Ubiquitin-Proteasome-mediated Degradation and Subcellular Localization of the Nuclear Receptor Coactivator GRIP1. J. Biol. Chem. 279: 49120-49130 [Abstract] [Full Text]  
  • Jin, Y., Zeng, S. X., Lee, H., Lu, H. (2004). MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation. J. Biol. Chem. 279: 20035-20043 [Abstract] [Full Text]  
  • Nawaz, Z., O'Malley, B. W. (2004). Urban Renewal in the Nucleus: Is Protein Turnover by Proteasomes Absolutely Required for Nuclear Receptor-Regulated Transcription?. Mol. Endocrinol. 18: 493-499 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»